Title: The Effects of Urineside on Immunity of Patients with Advanced Non-small Cell Lung Cancer
Abstract: To evaluate the effect of Urineside on immunity of patients with advanced non-small cell lung cancer.Forty-five patients with advanced non-small cell lung cancer were enrolled.Twenty-six patients received chemotherapy with NVB+DDP and 19 patients received the same regiment combined with Urineside for 4 to 8 weeks.The changes of T-lymphocyte subgroups were measured with the flow cytometry method before and after 2 cycles chemotherapy in the patients.The ratio of CD4+/CD8+ in patients with advanced non-small cell lung cancer before chemotherapy was significantly lower than that in control group(P0.05). In the chemotherapy group, the count of CD3+?CD4+ cells and the ratio of CD4+/CD8+ lowered after chemotherapy(P0.05), that indicates the immunity decreased after chemotherapy.In the Urineside group,no significant changes of CD3+ cells and the ratio of CD4+/CD8+ pre- and post-treatment were observed (P0.05), the immunity had no significant changes.After chemotherapy,CD3+ and CD4+ cells and the ratio of CD4+/CD8+ of the two groups had significant difference,the immunity in Urineside group was obviously higher than that in chemotherapy group.[Conclusion]The immunity is suppressed in the patients with advanced non-small cell lung cancer.The immunity lowers after chemotherapy.Urineside can improve the cell immunity in patients undergoing chemotherapy.
Publication Year: 2004
Publication Date: 2004-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot